Key result
The GlucoDr.S blood glucose monitoring system demonstrated acceptable performance according to ISO 15197:2013 guidelines, with over 95% of measurements falling within the required accuracy limits.
Observational (n=120)
No
Supports GlucoDr.S evaluation; leaves open need for independent validation before clinical adoption.
Background: The performance of the self-monitoring of blood glucose in patients with diabetes should be properly evaluated to ensure strict glycemic control. This study evaluated the self-testing Blood Glucose Monitoring System GlucoDr.S™ (All Medicus Co., Ltd., Korea). Methods: This study recruite...
No takes yet. Share an insight, caveat, or question.
Kim et al. (2018) conducted an observational in Diabetes (n=120). GlucoDr.S blood glucose monitoring system vs. YSI 2300 STAT PLUS Glucose Analyzer was evaluated on System accuracy (percentage of samples within ±15 mg/dL for <100 mg/dL and ±15% for ≥100 mg/dL). The GlucoDr.S blood glucose monitoring system demonstrated acceptable performance according to ISO 15197:2013 guidelines, with over 95% of measurements falling within the required accuracy limits.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: